Top Bioresorbable Polymers Companies

Global Bioresorbable Polymers Market size was valued at USD 4.19 Billion in 2024 and is poised to grow from USD 4.62 Billion in 2025 to USD 10.13 Billion by 2033, growing at a CAGR of 10.3% during the forecast period (2026–2033). 

The global bioresorbable polymers industry is highly competitive, with key players focusing on innovation, strategic partnerships, and expanding their product portfolios to maintain a strong market presence. Corbion N.V. is a global leader in sustainable solutions, specializing in lactic acid and its derivatives, which are used in medical applications such as drug delivery systems and sutures. Evonik Industries AG is another major player, offering high-performance bioresorbable polymers designed for implantable devices, tissue engineering, and controlled drug release applications. 'Corbion NV (Netherlands) ', 'Evonik Industries AG (Germany) ', 'Foster Corporation (United States) ', 'KLS Martin Group (Germany) ', 'DSM Biomedical (United States) ', 'Ashland Global Holdings Inc. (United States) ', 'Zeus Company LLC (United States) ', 'Seqens (France) ', 'REVA Medical LLC (United States) ', 'Poly-Med Incorporated (United States) ', 'Bezwada Biomedical LLC (United States) ', 'Nomisma Healthcare Pvt. Ltd. (India) ', 'BMG Incorporated (United States) ', 'Polysciences Inc. (United States) ', 'Huizhou Foryou Medical Devices Co. Ltd. (China) ', 'Musashino Chemical Laboratory Ltd. (Japan) ', 'Henan Xinghan Biotechnology Co. Ltd. (China) ', 'Covestro AG (Germany) ', 'International Polymer Engineering (United States) ', 'Mitsui Chemicals (Japan)'

As environmental sustainability continues to gain momentum, bioresorbable polymers are positioned as the more sustainable substitute to traditional plastics. Industries such as packaging, automotive, and agriculture are increasingly seeking sustainable materials that naturally decompose, and bioresorbable polymers offer a promising solution. Increasing plastic waste concerns and heightened regulatory pressure on environmental impact are pushing these materials into diverse non-medical applications.

Growing Demand for Medical Applications: Increasing usage of bioresorbable polymers in medicine is being noticed due to the special feature of being naturally degraded within the body and hence not requiring surgical removal. They are most valuable in applications like drug delivery systems, tissue engineering, and surgical sutures. They also have a broad range of applications in orthopedic implants, cardiovascular devices, and wound healing. As the global healthcare market expands with the aging population and its increasing demand for minimally invasive procedures, bioresorbable polymers will see increased demand.

North America dominated the industry and accounted for the largest revenue share of 33.5% in 2024. This is attributed to the increasing product consumption in drug delivery and orthopedics applications in the region. The U.S. is the major hub for research & development in the healthcare industry, further driving the market growth in North America. Moreover, the rising demand for orthopedics and drug delivery applications supports the bioresorbable polymers demand in the region. According to the data provided by the American Joint Replacement Registry (AJRR) in 2022, over 2.8 million knee and hip procedures were performed across 1,250 health institutions in the U.S. This signifies a remarkable 14% increase in cumulative registered procedural volume compared to the previous year, establishing the AJRR as the world's largest arthroplasty registry in terms of volume.